Latest Juvenile Diabetes Research Foundation Stories
skoopz® Launches Social Media Campaign to Raise Money for Juvenile Diabetes Research Foundation Maker of all-natural sugar substitute hopes fundraiser will ring sweet note Atlanta (Vocus/PRWEB) January 04, 2011 Atlanta-based skoopz®, the all-natural sugar substitute with no aftertaste, is hoping to help the Dallas Chapter of the Juvenile Diabetes Research Foundation (JDRF) reach a "sweet note" with donations. This January, skoopz will donate 10 percent of all of its online...
Walk Scheduled for January 29, 2011 Sioux Falls, SD (Vocus/PRWEB) December 30, 2010 The Juvenile Diabetes Research Foundation's annual Walk to Cure Diabetes will be held on Saturday, January 29 at The Empire Mall in Sioux Falls from 8 a.m. to noon. With a goal to raise $275,000 for research to find a cure for diabetes and its complications more than 3,000 local walkers are expected to attend. Last year, The Walk drew more than 2,500 people, who represented local corporations, families,...
The all-new Ultimate Diabetes Supplementâ„¢ is now available. Exclusively developed by a diabetic specifically for the benefit of other diabetics, this product is packed with 23 ingredients proven to help diabetics and is backed by a 100% money back guarantee. In addition, Diabetic Nutraceutical Labs has pledged to donate $2 from every bottle sold to leading diabetes charities to help fund the search for a cure. Long Beach, CA (PRWEB) December 13, 2010 The New Ultimate Diabetes...
A Statement from JDRF President and CEO, Jeffrey Brewer NEW YORK, Dec. 9, 2010 /PRNewswire-USNewswire/ -- "Today Congress passed a multi-year renewal of the Special Diabetes Program (SDP), ensuring that studies on promising diabetes treatments and avenues toward a cure continue uninterrupted. As the father of a son living with type 1 diabetes, and as CEO of JDRF, one of the leading advocates for the renewal of this program, I applaud the U.S. government for its continued commitment to end...
WASHINGTON, Nov. 30, 2010 /PRNewswire-USNewswire/ -- The Partnership for a Healthier America today announced it has appointed Lawrence (Larry) Soler to serve as President and CEO. Soler, currently the Chief Operating Officer for the Juvenile Diabetes Research Foundation (JDRF), will start his new position January 1, 2011. "Working with our full Board, we considered a number of exceptional candidates who want to help us achieve our goal of eliminating childhood obesity within a...
Clinical proof-of-concept study will also evaluate whether metreleptin can reduce the amount of insulin needed by patients with type 1 diabetes NEW YORK and SAN DIEGO, Nov. 16, 2010 /PRNewswire-USNewswire/ -- The Juvenile Diabetes Research Foundation (JDRF) and Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) announced today that they entered into a research collaboration agreement to provide financial support for a clinical proof-of-concept study to investigate the effects of metreleptin, an...
Experts present at FDA-NIH workshopDiabetes experts at a meeting convened by the U.S. Food and Drug Administration (FDA) and the National Institutes of Health (NIH) took the next step in advancing efforts toward the development of an artificial pancreas: putting forth clinical recommendations to ensure the safe and effective testing of artificial pancreas technology in real-life situations. We are pleased at today's meeting there was a strong consensus among leading clinicians, researchers...
ST. LOUIS, Nov. 8, 2010 /PRNewswire-USNewswire/ -- Build-A-Bear Workshop(®), the interactive entertainment retailer of customized stuffed animals, announced today that it is raising funds for the Juvenile Diabetes Research Foundation (JDRF) throughout the month of November as part of National Diabetes Awareness Month. In an effort to support research to help find better treatments and a cure for type 1 diabetes, Build-A-Bear Workshop Guests can support JDRF by adding a $1 donation to...
Renewal of U.S. Government Special Diabetes Program Will Ensure Progress toward Better Treatments and a Cure for Type 1 Diabetes NEW YORK, Nov. 5, 2010 /PRNewswire-USNewswire/ -- Thanks to significant research advances in recent years, people living with type 1 diabetes have received better treatments and therapies. Scientists have made headway in uncovering the possible cause of type 1 diabetes, and in their efforts to find ways to prevent, treat, or reverse the autoimmune disease and its...
CAMBRIDGE, Mass., Nov. 2 /PRNewswire/ -- Tolerx, Inc., a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by modulating T cell activity, announced today that it has established a Scientific Advisory Board to help advance the company's research and clinical studies in type 1 diabetes. This Scientific Advisory Board will support the scientific advancements that underlie the company's lead drug candidate, otelixizumab, as well as guide the creation...
